Search results
Author(s):
Simon Ermakov
,
Melvin Scheinman
Added:
3 years ago
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterised by progressive replacement of the ventricular myocardium by fibrofatty tissue.1 Patients with the disease are predisposed to ventricular arrhythmias, heart failure and sudden cardiac death.
Pathophysiology
ARVC has a strong genetic basis with most disease variants displaying an autosomal dominant…
View more
Author(s):
Sebastian Clauss
,
Moritz F Sinner
,
Stefan Kääb
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia experienced in clinical practice, and is responsible for significant morbidity and mortality.1 It affects more than 6 million people in Europe.1 The lifetime risk of developing AF after the age of 40 is approximately 25 %.1 AF is a major public health burden as it is associated with an increased risk of stroke by fivefold, dementia by twofold…
View more
Author(s):
Jaber Abboud
,
Joachim R Ehrlich
Added:
3 years ago
Implantable cardioverter defibrillators (ICDs) have been used for over 30 years to prevent sudden cardiac death (SCD). The first indications for ICD placement were secondary prevention; later trials demonstrated a primary prevention benefit of ICD therapy in patients at risk of SCD. ICD therapy prolongs life in both patient populations.1 However, the efficacy of an ICD depends on its ability to…
View more
Author(s):
Douglas Packer
Added:
5 years ago
ProfessorDouglas L. Packer discusses the CABANA trial - catheter ablation vs. antiarrhythmic drug therapy for atrial fibrillation.
Filmed on-site at HRS 2018 in Boston, US.
View more
Author(s):
Abhishek Maan
,
Moussa Mansour
,
Jeremy N Ruskin
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice.1 It has been estimated that >3million people in the US and >4.5 million in the EU have paroxysmal or persistent AF.2–4 AF is associated with an approximately fivefold increased risk of stroke,5 threefold risk of heart failure,6 diminished quality of life7 and increased healthcare costs.8,9…
View more
Author(s):
Steven Back
,
Peter R Kowey
Added:
3 years ago
Ventricular arrhythmias are a therapeutic challenge. They occur frequently in clinical practice, are found in patients with and without structural heart disease, and most importantly, are unpredictable and potentially deadly. Patients with a history of sustained ventricular tachycardia (VT) and VF or those at high risk for such arrhythmias, may require an ICD to prevent sudden cardiac arrest…
View more
Author(s):
Angela Hall
,
Andrew RJ Mitchell
Added:
3 years ago
AF is the most common clinical arrhythmia, affecting at least 1–2% of the population.1,2 Its prevalence increases with age, with 5% of people aged over 65 years developing AF, climbing to 8% in those aged over 75 years.3 AF is associated with increased morbidity and mortality and has significant public health implications.4 Patients presenting with new onset AF to emergency departments can be…
View more
Author(s):
Carina Blomström-Lundqvist
,
Helmut Pürerfellner
,
Alex White
,
et al
Added:
3 years ago
Author(s):
Oholi Tovia-Brodie
,
Yoav Michowitz
,
Bernard Belhassen
Added:
3 years ago
Brugada syndrome (BrS) is a cardiac disease caused by an inherited ion channelopathy. It was first described by the Brugada brothers in 19921 and is associated with a propensity to develop ventricular fibrillation (VF). Brugada syndrome is characterised by prominent J waves appearing as an ST segment elevation in the right precordial leads. In the latest guidelines, diagnosis of BrS constitutes…
View more
Author(s):
Pok Tin Tang
,
Duc H Do
,
Anthony C Li
,
et al
Added:
3 years ago
Ventricular arrhythmias remain a major contributor to cardiac morbidity and mortality worldwide, despite ongoing research and implementation of novel therapeutic interventions. Modern management of patients with ventricular arrhythmias requires a multidisciplinary team approach, especially in complex presentations with a background of multiple medical comorbidities.1,2 Such teams may include…
View more